Want to master the CMO role? Join us for GrowthBeat Summit on June 1-2 in Boston
, where we'll discuss how to merge creativity with technology to drive growth. Space is limited and we're limiting attendance to CMOs and top marketing execs. Request your personal invitation here
VaxInnate, a Cranbury, N.J., vaccine-focused biotech, received a $597,000 small-business innovation grant from the NIH to support work on a vaccine against Dengue fever, a mosquito-borne viral disease. VaxInnate’s primary focus is on new influenza vaccines that are designed to stimulate “toll-like receptors” that can produce a more robust immune response. The company’s description of its technology is here.
VentureBeat’s VB Insight team is studying email marketing tools.
Chime in here, and we’ll share the results